Hubungan Derajat Skor CURB-65 Saat Awal Masuk Pada Pasien Pneumonia Komunitas Terhadap Nilai Antithrombin III (AT-III)
DAFTAR PUSTAKA
Abidin A. Management of Community Acquired Pneumonia. Dalam : Naskah lengkap
11th Annual Scientific meeting Internal Medicine 2010. Semarang. Badan penerbit USU
press.2010; p. 132-42.
Abraham E. (2000) Coagulation Abnormalities in Acute Lung Injury and Sepsis. Am. J.
Respir. Cell Mol. Biol. 22:401–4.
Agapakis DI, Tsantilas D, Psarris P, Massa EV, KotsaftisP, Konstantinos Tziomalos K,
Hatzitolios AI. Coagulation and Inflammation Biomarkers May Help Predict The
Severity of Community-Acquired Pneumonia. Respirology.2010; 15: 796-803.
American College of Chest Physicians/Society of Critical Care Medicine Consensus
Conference: Definitions for Sepsis and Organ Failure and Guidelines for The Use of
InnovativeTherapies in Sepsis. Critical Care Medicine, 1992. Vol 20 no 6.and Prevention
National Center for Health Statistics National Vital Statistics System. Deaths: final data.
National Vital Statistics Reports, 2011.Vol. 61, No. 6.
Arash A, et al.Antithrombin III in critically ill patients: Systematic Review with MetaAnalysis and Trial Sequential Analysis.BMJ.2007 : 1-9.
Capelastegui A, Espana PP, Quintana JM, Arcitio I, Gorondo I, Egurolla M, et.al.
Validation of Predictive Rule for the Management of Community Acquired Pneumoniae.
Eur Respir J. 2006; 27: 151-57.
Choi G, Scultz MJ, van Till JWO et al. Disturbed Alveolar Fibrin Turnover During
Pneumonia is Restricted to The Site of Infection. Eur. Respir. J. 2004; 24: 786–9.
Universitas Sumatera Utara
29
ii
Christ-Crain M, Opal SM. Clinical Review: The Role of Biomarkers in the Diagnosis and
Management of Community Acquired Pneumonia. Critical care.2010; 14: 1- 11.
Dahlan Z, Pneumonia. Dalam: Sudoyo AW, Setyohadi B, Alwi I, Simadibrata M, Setiati
S (editors).Buku Ajar Ilmu Penyakit Dalam.Jakarta 2009;2196-2205.
De Frances CJ, Lucas CA, Buie VC, Golosinskiy A. 2006 National Hospital Discharge
Survey. National Health Statistic Reports. 2008;5: 1-20.
Donna L. Hoyert, Ph.D. and Jiaquan Xu, M.D.; Centers for Disease Control and
Prevention National Center for Health Statistics National Vital Statistics
System.
Deaths: final data. National Vital Statistics Reports, 2011.Vol. 61, No. 6.
Escobar CE, et al., Introduction to hemostasis. In: Harmening DM, ed. Clinical
Hematology and Fundamentals of Hemostasis. 4th ed. Philadelphia, PA: FA Davis
Company; 2002:441-470.
Fourreir F, et al Septic Shock, Multiple Organ Failure and Disseminated Intravascular
Coagulation Compared Pattern of Antithrombin III, Protein C and Protein S Deficiencies.
Hardiyanto UM.Tinjauan beberapa aspek penderita Pneumonia yang dirawat di
SMF/Bagian IP Dalam RSUP Hasan Sadikin, Bandung tahun 1995-1996. FK Unpad
1998.
Huang HH, Zhang YY, Xiu QY, et al. Community-Acquired Pneumonia in
Shanghai,China: Microbial Etiology and Implications for Empirical Therapy in a
Prospective Study of 389 patients. Eur J Clin Microbiol Infect Dis 2006;25:369–74.
Idell S. Coagulation, Fibrinolysis and Fibrin Deposition in Acute Lung Injury. Crit. Care
Med. 2003; 31: S213–20.
Jerry B.L,Coagulation Pathway and Physiology.An Algorithmic Approach to Hemostasis
Testing, 2008 – PK staging.PK.org.
Universitas Sumatera Utara
30
Kaplan V, Clermont G, Griffin MF, Kasal J, Watson RS, Linde-Zwirble WT, et.al.
Pneumonia: Still the Oldman’s Friend. Arch Intern Med. 2003; 163: 317-23
Kasper, Braunwald, Fauci, Hauser, Longo, Jameson(Editors). Sepsis and Septic Shock.
Harrison’s Manual Of Medicine, 18 th Edition, Mc Graw Hill, 2005:49-53
Laterre PF, Garber G, Levy H, Wunderink R, Kinasewitz GT, Sollet JP, et.al. Severe
Community Acquired Pneumoniae As Cause Of Severe Sepsis: Data from PROWESS
study. Crit Care Med, 2005; 33(5): 952-61.
Levi M, Schultz MJ, Rijneveld AW, van der Poll T. Bronchoalveolar Coagulation and
Fibrinolysis in Endotoxemia and Pneumonia. Crit Care Med.2003;31:238-42.
Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Jeune IL, et.al. British
Thoracic Society Guidelines For The Management of Community Acquired Pneumoniain
Adults: update 2009. Thorax. 2009; 64(suppl II) : 1- 55.
Mandell LA, Wunderik RG, Arzueto A, Bartlett JG, Campbell GD, Dean NC, et.al.
Infectious Diseases Society of America/ American Thoracic Society Consensus
Guidelines on The Management of Community Acquired Pneumonia in Adults. CID.
2007; 44: 27- 72.
Marianne N, Richard J. B, Coagulation Dysfunction in Sepsis and Multiple Organ
System Failure. Crit Care Clin 19 (2003) 441 – 458.
Milbrandt EB, Reade MC, Lee MJ, Shook SL, Angus DC, Kong L, et al. Prevalence and
Significance of Coagulation Abnormalities in Community-acquired Pneumonia.
Molecular medicine. 2009; 15(11-12): 438–445.
Mira JP, Max A, Burgel PR. The Role of Biomarker in Community Acquired Pneumonia:
Prediciting Mortality and Response to Adjunctive Therapy. Critical Care. 2008;12(Suppl
6): 1-7.
31
Universitas Sumatera Utara
Muller B, Harbarth S, Stolz D, Bingisser R, Mueller C, Leuppi J, et.al. Diagnostic and
Prognostic Accuracy of Clinical and Laboratory Parameters in Community Acquired
Pneumonia. BMC Infectious Diseases.2007; 7: 1- 10.
Perhimpunan Dokter Paru Indonesia.Pneumonia Komunitas, pedoman diagnosis &
penatalaksanaan di Indonesia. Jakarta: PDPI, 2003. h.1-38
Pettilä V,Pentti J,Pettilä M,Takkunen O, Jousela I,et al.Predictive Value of Antithrombin
III and Serum C-reactive Protein Concentration in cCitically Ill Patients with Suspected
Sepsis.Crit Care Med 2002; 30:271–275.
Proietta M, Pulignano I, Porto F et al. Antithrombin III Metabolism In The pulmonary
Vessel Endothelium. Blood Coagul. Fibrinolysis 2007; 18: 237–40.
Ribelles JMQ, Tenias JM, Grav E, Querol-Borras JM, Climent JL, Gomez E, et.al.
Plasma d-dimer levels Correlate with Outcomes in Patient with Community Acquired
Pneumonia. Chest.2004; 126: 1087-92.
Rijneveld AW, et al. (2006) Local Activation of The Tissue Factor-factor VIIa Pathway
in Patients with Pneumonia and The Effect of Inhibition of This Pathway in Murine
Pneumococcal Pneumonia. Crit. Care Med. 34:1725–730.
S. Ewig et al.Severity Assessment in Community-Acquired PneumoniaeEur Respir J
2000; 16: 1193-1201.
Saito A, Kohno S, Matsushima T, et al. Prospective Multicenter Study of The Causative
Organisms of Community-Acquired Pneumonia in Adults in Japan. J Infect Chemother
2006;12:63–9.
Singanayagam A, Chalmers JD, Hill AT. Severity Assesment in Community Acquired
Pneumonia: a review. QJ med. 2009; 102: 379-88.
Suharti. Dasar-dasar HemostasisDalam: Sudoyo AW, Setyohadi B, Alwi I, Simadibrata
M, Setiati S (editors).Buku Ajar Ilmu Penyakit Dalam.Jakarta 2009;1293-1300.
Summary Executive. Pola Penyakit Penyebab Kematian di Indonesia. Survei Kesehatan
Rumah Tangga (SKRT). 2001: 2.
32
Universitas Sumatera Utara
Thomas M F, Jr, MD, Prognosis of Community-Acquired Pneumonia in adults. 2011,
available in: http://www.uptodate.com.
Torres A. Update in Community-acquired and Nosocomial Pneumoniae. Pulmonary and
Critical Care Updates.Am J Respir Crit Care Med Vol 181. pp 782–787, 2010.
Wattanathum A, Chaoprasong C, Nunthapisud P, et al. Community-Acquired Pneumonia
in southeast Asia: The Microbial Differences Between Ambulatory and Hospitalized
Patients. Chest 2003;123:1512–9.
33
Universitas Sumatera Utara
Abidin A. Management of Community Acquired Pneumonia. Dalam : Naskah lengkap
11th Annual Scientific meeting Internal Medicine 2010. Semarang. Badan penerbit USU
press.2010; p. 132-42.
Abraham E. (2000) Coagulation Abnormalities in Acute Lung Injury and Sepsis. Am. J.
Respir. Cell Mol. Biol. 22:401–4.
Agapakis DI, Tsantilas D, Psarris P, Massa EV, KotsaftisP, Konstantinos Tziomalos K,
Hatzitolios AI. Coagulation and Inflammation Biomarkers May Help Predict The
Severity of Community-Acquired Pneumonia. Respirology.2010; 15: 796-803.
American College of Chest Physicians/Society of Critical Care Medicine Consensus
Conference: Definitions for Sepsis and Organ Failure and Guidelines for The Use of
InnovativeTherapies in Sepsis. Critical Care Medicine, 1992. Vol 20 no 6.and Prevention
National Center for Health Statistics National Vital Statistics System. Deaths: final data.
National Vital Statistics Reports, 2011.Vol. 61, No. 6.
Arash A, et al.Antithrombin III in critically ill patients: Systematic Review with MetaAnalysis and Trial Sequential Analysis.BMJ.2007 : 1-9.
Capelastegui A, Espana PP, Quintana JM, Arcitio I, Gorondo I, Egurolla M, et.al.
Validation of Predictive Rule for the Management of Community Acquired Pneumoniae.
Eur Respir J. 2006; 27: 151-57.
Choi G, Scultz MJ, van Till JWO et al. Disturbed Alveolar Fibrin Turnover During
Pneumonia is Restricted to The Site of Infection. Eur. Respir. J. 2004; 24: 786–9.
Universitas Sumatera Utara
29
ii
Christ-Crain M, Opal SM. Clinical Review: The Role of Biomarkers in the Diagnosis and
Management of Community Acquired Pneumonia. Critical care.2010; 14: 1- 11.
Dahlan Z, Pneumonia. Dalam: Sudoyo AW, Setyohadi B, Alwi I, Simadibrata M, Setiati
S (editors).Buku Ajar Ilmu Penyakit Dalam.Jakarta 2009;2196-2205.
De Frances CJ, Lucas CA, Buie VC, Golosinskiy A. 2006 National Hospital Discharge
Survey. National Health Statistic Reports. 2008;5: 1-20.
Donna L. Hoyert, Ph.D. and Jiaquan Xu, M.D.; Centers for Disease Control and
Prevention National Center for Health Statistics National Vital Statistics
System.
Deaths: final data. National Vital Statistics Reports, 2011.Vol. 61, No. 6.
Escobar CE, et al., Introduction to hemostasis. In: Harmening DM, ed. Clinical
Hematology and Fundamentals of Hemostasis. 4th ed. Philadelphia, PA: FA Davis
Company; 2002:441-470.
Fourreir F, et al Septic Shock, Multiple Organ Failure and Disseminated Intravascular
Coagulation Compared Pattern of Antithrombin III, Protein C and Protein S Deficiencies.
Hardiyanto UM.Tinjauan beberapa aspek penderita Pneumonia yang dirawat di
SMF/Bagian IP Dalam RSUP Hasan Sadikin, Bandung tahun 1995-1996. FK Unpad
1998.
Huang HH, Zhang YY, Xiu QY, et al. Community-Acquired Pneumonia in
Shanghai,China: Microbial Etiology and Implications for Empirical Therapy in a
Prospective Study of 389 patients. Eur J Clin Microbiol Infect Dis 2006;25:369–74.
Idell S. Coagulation, Fibrinolysis and Fibrin Deposition in Acute Lung Injury. Crit. Care
Med. 2003; 31: S213–20.
Jerry B.L,Coagulation Pathway and Physiology.An Algorithmic Approach to Hemostasis
Testing, 2008 – PK staging.PK.org.
Universitas Sumatera Utara
30
Kaplan V, Clermont G, Griffin MF, Kasal J, Watson RS, Linde-Zwirble WT, et.al.
Pneumonia: Still the Oldman’s Friend. Arch Intern Med. 2003; 163: 317-23
Kasper, Braunwald, Fauci, Hauser, Longo, Jameson(Editors). Sepsis and Septic Shock.
Harrison’s Manual Of Medicine, 18 th Edition, Mc Graw Hill, 2005:49-53
Laterre PF, Garber G, Levy H, Wunderink R, Kinasewitz GT, Sollet JP, et.al. Severe
Community Acquired Pneumoniae As Cause Of Severe Sepsis: Data from PROWESS
study. Crit Care Med, 2005; 33(5): 952-61.
Levi M, Schultz MJ, Rijneveld AW, van der Poll T. Bronchoalveolar Coagulation and
Fibrinolysis in Endotoxemia and Pneumonia. Crit Care Med.2003;31:238-42.
Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Jeune IL, et.al. British
Thoracic Society Guidelines For The Management of Community Acquired Pneumoniain
Adults: update 2009. Thorax. 2009; 64(suppl II) : 1- 55.
Mandell LA, Wunderik RG, Arzueto A, Bartlett JG, Campbell GD, Dean NC, et.al.
Infectious Diseases Society of America/ American Thoracic Society Consensus
Guidelines on The Management of Community Acquired Pneumonia in Adults. CID.
2007; 44: 27- 72.
Marianne N, Richard J. B, Coagulation Dysfunction in Sepsis and Multiple Organ
System Failure. Crit Care Clin 19 (2003) 441 – 458.
Milbrandt EB, Reade MC, Lee MJ, Shook SL, Angus DC, Kong L, et al. Prevalence and
Significance of Coagulation Abnormalities in Community-acquired Pneumonia.
Molecular medicine. 2009; 15(11-12): 438–445.
Mira JP, Max A, Burgel PR. The Role of Biomarker in Community Acquired Pneumonia:
Prediciting Mortality and Response to Adjunctive Therapy. Critical Care. 2008;12(Suppl
6): 1-7.
31
Universitas Sumatera Utara
Muller B, Harbarth S, Stolz D, Bingisser R, Mueller C, Leuppi J, et.al. Diagnostic and
Prognostic Accuracy of Clinical and Laboratory Parameters in Community Acquired
Pneumonia. BMC Infectious Diseases.2007; 7: 1- 10.
Perhimpunan Dokter Paru Indonesia.Pneumonia Komunitas, pedoman diagnosis &
penatalaksanaan di Indonesia. Jakarta: PDPI, 2003. h.1-38
Pettilä V,Pentti J,Pettilä M,Takkunen O, Jousela I,et al.Predictive Value of Antithrombin
III and Serum C-reactive Protein Concentration in cCitically Ill Patients with Suspected
Sepsis.Crit Care Med 2002; 30:271–275.
Proietta M, Pulignano I, Porto F et al. Antithrombin III Metabolism In The pulmonary
Vessel Endothelium. Blood Coagul. Fibrinolysis 2007; 18: 237–40.
Ribelles JMQ, Tenias JM, Grav E, Querol-Borras JM, Climent JL, Gomez E, et.al.
Plasma d-dimer levels Correlate with Outcomes in Patient with Community Acquired
Pneumonia. Chest.2004; 126: 1087-92.
Rijneveld AW, et al. (2006) Local Activation of The Tissue Factor-factor VIIa Pathway
in Patients with Pneumonia and The Effect of Inhibition of This Pathway in Murine
Pneumococcal Pneumonia. Crit. Care Med. 34:1725–730.
S. Ewig et al.Severity Assessment in Community-Acquired PneumoniaeEur Respir J
2000; 16: 1193-1201.
Saito A, Kohno S, Matsushima T, et al. Prospective Multicenter Study of The Causative
Organisms of Community-Acquired Pneumonia in Adults in Japan. J Infect Chemother
2006;12:63–9.
Singanayagam A, Chalmers JD, Hill AT. Severity Assesment in Community Acquired
Pneumonia: a review. QJ med. 2009; 102: 379-88.
Suharti. Dasar-dasar HemostasisDalam: Sudoyo AW, Setyohadi B, Alwi I, Simadibrata
M, Setiati S (editors).Buku Ajar Ilmu Penyakit Dalam.Jakarta 2009;1293-1300.
Summary Executive. Pola Penyakit Penyebab Kematian di Indonesia. Survei Kesehatan
Rumah Tangga (SKRT). 2001: 2.
32
Universitas Sumatera Utara
Thomas M F, Jr, MD, Prognosis of Community-Acquired Pneumonia in adults. 2011,
available in: http://www.uptodate.com.
Torres A. Update in Community-acquired and Nosocomial Pneumoniae. Pulmonary and
Critical Care Updates.Am J Respir Crit Care Med Vol 181. pp 782–787, 2010.
Wattanathum A, Chaoprasong C, Nunthapisud P, et al. Community-Acquired Pneumonia
in southeast Asia: The Microbial Differences Between Ambulatory and Hospitalized
Patients. Chest 2003;123:1512–9.
33
Universitas Sumatera Utara